Quick Links

Control HAE types I and II with a pill instead of injections!

Control HAE types I and II with a pill instead of injections!

No More Needles to Prevent HAE Attacks? We need you to help us find out.

Right now, patients are being enrolled in the APeX-S study, a worldwide clinical research study to investigate the long-term safety of an investigational oral medication to prevent hereditary angioedema (HAE) attacks.

If you have Type I or II HAE, have used androgen therapy, and are interested in learning about an oral medication that could become an alternative to injections or infusions to prevent attacks, then see if you qualify.

You can find additional information about APeX-S at

Seattle Allergy & Asthma Research Institute
9725 Third Ave. NE, Suite 500
Seattle, WA 98115
studies@asthmainc.org
www.seattleallergy.org

Participant Eligibility

Type 1 and Type 2 HAE
12 years and older

Contact

Ramon Soria
(206) 525-5520 x1181

Additional Study Details

Full Study Title
HAE Trial BCX7353

Study ID: BCX7353-204
Start Date: 10/01/2019
End Date: 11/30/2020

Investigator(s)
Daniel Petroni

Accepts Healthy Volunteers?
No

Study Site(s)

Seattle Allergy and Asthma Research Institute

9725 3rd Ave NE STE 500
Seattle, Washington 98115



Interested?

Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.

SITE PARTNERS
uw-footer